Takeda Pharmaceutical Non-GAAP EPS of ¥151.00, revenue of ¥1106.7B; reaffirms FY outlook
Source: SeekingAlpha
2025-07-30 03:20:35 ET
More on Takeda Pharmaceutical
- Takeda: Positioned To Tackle Future Clinical Demand In A Highly Regulated Sector
- Takeda: Positives And Negatives Offset Each Other
- Takeda Pharmaceuticals Caps A Strong Year, Guidance Suggests Dividend Is On The Rise
- Takeda sees positive late-stage results for oveporexton in narcolepsy
- Takeda, Pfizer's Adcetrix wins EU approval for hodgkin lymphoma
Read the full article on Seeking Alpha
For further details see:
Takeda Pharmaceutical Non-GAAP EPS of ¥151.00, revenue of ¥1106.7B; reaffirms FY outlook
Takeda Pharmaceutical Co Ltd
NASDAQ: TKPHF
TKPHF Trading
6.99% G/L:
$36.055 Last:
195 Volume:
$36.055 Open:
TKPHF Latest News
TKPHF Stock Data
$55,801,616,447
1,559,387,460
N/A
724
N/A
Pharmaceuticals
Healthcare
JP
Chuo-ku
